Xinmin Nie

1.6k total citations
56 papers, 1.3k citations indexed

About

Xinmin Nie is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Xinmin Nie has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 11 papers in Cancer Research and 11 papers in Biomedical Engineering. Recurrent topics in Xinmin Nie's work include MicroRNA in disease regulation (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Cancer-related molecular mechanisms research (7 papers). Xinmin Nie is often cited by papers focused on MicroRNA in disease regulation (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Cancer-related molecular mechanisms research (7 papers). Xinmin Nie collaborates with scholars based in China and Canada. Xinmin Nie's co-authors include Rong Gui, Rong Huang, Ming Zhou, Junhua Zhang, Rong Gui, Juanjuan Xiang, Shourong Shen, Xueyuan Huang, Jian‐Hui Jiang and Jian Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Carbon.

In The Last Decade

Xinmin Nie

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinmin Nie China 22 747 387 247 202 175 56 1.3k
Mir Hadi Jazayeri Iran 13 618 0.8× 354 0.9× 173 0.7× 171 0.8× 120 0.7× 34 1.1k
Fang Gao China 16 588 0.8× 341 0.9× 336 1.4× 239 1.2× 118 0.7× 48 1.2k
Wang Sheng China 20 751 1.0× 465 1.2× 369 1.5× 178 0.9× 455 2.6× 50 1.6k
Zhijin Fan China 21 621 0.8× 604 1.6× 181 0.7× 212 1.0× 169 1.0× 47 1.2k
Yan Tang United States 14 630 0.8× 519 1.3× 114 0.5× 217 1.1× 251 1.4× 33 1.4k
Tian Gao China 26 973 1.3× 535 1.4× 168 0.7× 159 0.8× 112 0.6× 78 1.7k
Benchen Rao China 14 395 0.5× 314 0.8× 106 0.4× 195 1.0× 187 1.1× 24 886
Xi Zhu China 17 857 1.1× 597 1.5× 172 0.7× 234 1.2× 492 2.8× 36 1.7k
Guoqiu Wu China 18 812 1.1× 292 0.8× 311 1.3× 196 1.0× 47 0.3× 62 1.1k

Countries citing papers authored by Xinmin Nie

Since Specialization
Citations

This map shows the geographic impact of Xinmin Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinmin Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinmin Nie more than expected).

Fields of papers citing papers by Xinmin Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinmin Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinmin Nie. The network helps show where Xinmin Nie may publish in the future.

Co-authorship network of co-authors of Xinmin Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Xinmin Nie. A scholar is included among the top collaborators of Xinmin Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinmin Nie. Xinmin Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Zhenzhen, Haiting Liu, Xinmin Nie, et al.. (2024). A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune. Journal of Nanobiotechnology. 22(1). 296–296. 6 indexed citations
3.
Lu, Lu, Jian Li, Xinmin Nie, et al.. (2023). Bioengineered stem cell membrane functionalized nanoparticles combine anti-inflammatory and antimicrobial properties for sepsis treatment. Journal of Nanobiotechnology. 21(1). 170–170. 15 indexed citations
4.
Huang, Yu‐Fen, Lu Lu, Xisheng Li, et al.. (2023). Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma. Journal of Nanobiotechnology. 21(1). 89–89. 28 indexed citations
5.
Huang, Yu‐Fen, Yanrong Su, Lu Lu, et al.. (2023). Erythrocyte membrane-camouflaged DNA-functionalized upconversion nanoparticles for tumor-targeted chemotherapy and immunotherapy. Nanoscale. 15(21). 9457–9476. 15 indexed citations
6.
Yan, Ying, Jian Li, Xi Zhou, et al.. (2022). A turn-on fluorescent strategy for alkaline phosphatase detection based on enzyme-assisted signal amplification. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 286. 121939–121939. 6 indexed citations
7.
Shang, Yinghui, Qinghai Wang, Jian Li, et al.. (2021). Zirconia Nanoparticles Induce HeLa Cell Death Through Mitochondrial Apoptosis and Autophagy Pathways Mediated by ROS. Frontiers in Chemistry. 9. 522708–522708. 19 indexed citations
8.
Li, Guiyin, Huiling Liu, Ping Ding, et al.. (2019). A fluorometric aptamer nanoprobe for alpha-fetoprotein by exploiting the FRET between 5-carboxyfluorescein and palladium nanoparticles. Microchimica Acta. 186(5). 314–314. 47 indexed citations
9.
Zhang, Junhua, Jing Jiang, Rong Huang, et al.. (2018). Circular RNA expression profiles are significantly altered in mice bone marrow stromal cells after total body irradiation. Leukemia Research. 70. 67–73. 12 indexed citations
10.
11.
Qiu, Ming, et al.. (2016). Oxidored-nitro domain-containing protein 1 expression is associated with the progression of hepatocellular carcinoma. Oncology Letters. 11(5). 3003–3008. 9 indexed citations
12.
Li, Jin, et al.. (2015). Therapeutic effects of acetylspiramycin and garlicin on cryptosporidiosis among drug users. International Journal for Parasitology Drugs and Drug Resistance. 5(3). 185–190. 14 indexed citations
13.
Nie, Xinmin, Rong Huang, Caixia Dong, et al.. (2014). Plasmonic ELISA for the ultrasensitive detection of Treponema pallidum. Biosensors and Bioelectronics. 58. 314–319. 59 indexed citations
14.
Xu, Dan, Ming Zhou, Bimei Jiang, et al.. (2012). Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells. Oncology Letters. 4(5). 941–946. 20 indexed citations
15.
Huang, Shuang, et al.. (2010). The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions. Medical Oncology. 28(S1). 547–552. 5 indexed citations
16.
Nie, Xinmin. (2009). Expression of platelet-derived growth factor-BB in patients with lung cancer. 1 indexed citations
17.
Nie, Xinmin, et al.. (2008). HSP70 Inhibits Burn Serum-Induced Apoptosis of Cardiomyocytes via Mitochondrial and Membrane Death Receptor Pathways. Journal of Burn Care & Research. 29(3). 512–518. 7 indexed citations
18.
Gui, Rong, et al.. (2006). Tacrolimus Dosing in Chinese Renal Transplant Patients Is Related to MDR1 Gene C3435T Polymorphisms. Transplantation Proceedings. 38(9). 2850–2852. 25 indexed citations
19.
Zhou, Ming, Cong Peng, Xinmin Nie, et al.. (2003). [Expression of BRD7-interacting proteins,BRD2 and BRD3, in nasopharyngeal carcinoma tissues].. PubMed. 22(2). 123–7. 8 indexed citations
20.
Xiang, Juanjuan, Jingqun Tang, Shiguo Zhu, et al.. (2003). IONP‐PLL: a novel non‐viral vector for efficient gene delivery. The Journal of Gene Medicine. 5(9). 803–817. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026